Education Library

Resources for Health Care Professionals

Filter Results

Condition

Audience

Topic

Type

Escalation Strategies in Cardiogenic Shock that Increase Unloading and Survival

Mark Anderson, MD presents his surgical perspectives on increasing survival in cardiogenic shock through escalation strategies that increase unloading.

Dhruva et al. 

This FAQ explains how the conclusions of Dhruva et al. conflict with Impella® best practice outcomes reported in more robust, previously published, contemporary, prospective studies.

Information for Physicians: Medical Office Review of Dhruva et al.

Seth Bilazarian, MD, identifies and discusses a number of limitations of the Dhurva et al. paper.

FAQ: Is There Randomized Controlled Trial Data Available for Impella® Heart Pump Use in Cardiogenic Shock?

This FAQ discusses the challenges of obtaining RCT data for cardiogenic shock and presents the clinical data that is currently available and ongoing.

Discover New Data on Protected PCI versus Bailout PCI

Alexander Truesdell, MD, discusses Protected PCI versus bailout PCI using data from the cVAD Study and the PROTECT III study. 

Amin Analysis: Review of Trends, Variation and Outcomes in Impella® Use

Seth Bilazarian, MD, reviews the shortcomings of the Amin, et al., analysis presented at AHA 2019.

How Do Bleeding Rates with Impella® Compare to Bleeding Rates Associated With Other Forms of Mechanical Circulatory Support?

This FAQ discusses bleeding rates associated with mechanical circulatory support and vascular access and closure techniques for successfully managing bleeding.

Top Cardiogenic Shock Treatment Objectives and Device Options

The goals of cardiogenic shock treatment are to restore blood flow and protect organs from damage. Learn more about signs, symptoms and treatment options.

NCSI Study: About 40% of AMICS Patients Develop Right Ventricular Dysfunction

Babar Basir, DO, discusses NCSI study findings on right ventricular dysfunction in AMI cardiogenic shock.

Looking to Clinical Evidence in Cardiogenic Shock

William O’Neill, MD discusses cardiogenic shock treatment in light of the lack of randomized, controlled clinical trial data for cardiogenic shock.

Door-to-Unload (DTU) in STEMI Trial Summary: Pilot Trial and Pivotal Trial Design

Navin K. Kapur, MD, FACC, FSCAI, FAHA, discusses how acute cardiac unloading limits infarct scar formation in the context of the DTU-STEMI Pilot trial and Pivotal trial.

Impella RP® Support for Univentricular Shock

Navin Kapur, MD, uses Impella RP to effectively manage univentricular shock in a patient with right ventricular failure.

Alternative Access Sites for Large Bore Procedures with Rajiv Tayal, MD

Rajiv Tayal, MD, discusses axillary access techniques for large bore procedures as well as other alternative access skills for advanced interventional operators.

What is the STEMI DTU™ Pivotal Trial?  

The STEMI DTU pivotal trial is a prospective, multicenter, two-arm randomized controlled trial that plans to enroll 668 patients undergoing treatment for a STEMI heart attack. 

Instituting a Cardiogenic Shock Protocol to Improve Outcomes

Alexander Truesdell, MD, and Behnam Tehrani, MD, discuss improved outcomes after implementing a cardiogenic shock protocol at Inova Heart and Vascular Institute. 

NPS-1674

This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].